Published Mon, 23 Jul 2018 18:14:21 -0400 on Seeking Alpha
Editor's note: Seeking Alpha is proud to welcome DivEngineer as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
While any portfolio of stocks can be successful in the right circumstances, we each attempt to find the best system for determining which stocks we want to purchase to make money. I have found that, for me, buying high quality dividend growth stocks at the proper time has the best results and fits best with my personal requirements. While the definition of quality varies, sometimes greatly, there are certain similar criteria that most quality driven portfolios utilize. I will be using the criteria I have found best to start a portfolio of dividend growth stocks that will be chosen based on quality and proper timing. This is not to say that we will attempt to time the market. But just as there are times where buying a low quality stock makes money, there are times that buying even a high quality stock does not make sense.
The goal of this and subsequent articles will be to identify stocks that meet the quality and buy criteria so that readers can make a decision of whether inclusion into their portfolio is appropriate. We will also create a model portfolio using this criteria in order to test it's effectiveness. As the effectiveness becomes clear, future articles will make necessary changes to... Read more
|Stock name||Last trade||P/E||Earnings/Share||Dividend/Share||Dividend yield|
Older articles featuring Medtronic (MDT):What Are The Highest Quality Dividend Growth Stocks?
My Dividend Growth Portfolio Update: 32 Holdings, 3 Buys, 1 Sale
10 Dividend Growth Stocks For February 2019
Nicholas Ward's Dividend Growth Portfolio: 2018 Review
My Dividend Growth Portfolio 2018 Review: 3 Sells, 6 Buys
New Device Could Solve the Opioid Crisis and Pay Dividends
My US Dividend Achievers And Canadian Wide Moat 7 Held Up 'Better' Than Benchmarks In 2018
My Dividend Growth Portfolio - Q4 2018 Summary
Share In Healthcare And Biotech Gains With 12% Yield From This Tekla Fund
3 Top Healthcare Dividend Stocks for 2019